These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31950385)

  • 1. MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes.
    Klæstad E; Opdahl S; Engstrøm MJ; Ytterhus B; Wik E; Bofin AM; Valla M
    Breast Cancer Res Treat; 2020 Feb; 180(1):73-86. PubMed ID: 31950385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.
    Valla M; Engstrøm MJ; Ytterhus B; Hansen ÅK; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
    Breast Cancer Res Treat; 2017 Apr; 162(2):243-253. PubMed ID: 28124285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis.
    Valla M; Opdahl S; Ytterhus B; Bofin AM
    Breast Cancer Res Treat; 2021 May; 187(1):57-67. PubMed ID: 33616774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes.
    Klæstad E; Sawicka JE; Engstrøm MJ; Ytterhus B; Valla M; Bofin AM
    Breast Cancer Res Treat; 2021 Feb; 186(1):65-77. PubMed ID: 33389351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAK1 copy number in breast cancer-Associations with proliferation and molecular subtypes.
    Skjervold AH; Valla M; Ytterhus B; Bofin AM
    PLoS One; 2023; 18(6):e0287608. PubMed ID: 37368917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial ribosomal small subunit proteins (MRPS) MRPS6 and MRPS23 show dysregulation in breast cancer affecting tumorigenic cellular processes.
    Oviya RP; Gopal G; Shirley SS; Sridevi V; Jayavelu S; Rajkumar T
    Gene; 2021 Jul; 790():145697. PubMed ID: 33964376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis.
    Valla M; Klæstad E; Ytterhus B; Bofin AM
    J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):67-77. PubMed ID: 35459982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of androgen receptors in breast cancer subtypes.
    Kraby MR; Valla M; Opdahl S; Haugen OA; Sawicka JE; Engstrøm MJ; Bofin AM
    Breast Cancer Res Treat; 2018 Nov; 172(2):283-296. PubMed ID: 30109519
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bofin AM; Ytterhus B; Klæstad E; Valla M
    J Clin Pathol; 2022 Jul; 75(7):459-464. PubMed ID: 33753561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
    Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
    BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial ribosomal small subunit (MRPS) MRPS23 protein-protein interaction reveals phosphorylation by CDK11-p58 affecting cell proliferation and knockdown of MRPS23 sensitizes breast cancer cells to CDK1 inhibitors.
    Oviya RP; Thangaretnam KP; Ramachandran B; Ramanathan P; Jayavelu S; Gopal G; Rajkumar T
    Mol Biol Rep; 2022 Oct; 49(10):9521-9534. PubMed ID: 35962848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.
    Pu M; Wang J; Huang Q; Zhao G; Xia C; Shang R; Zhang Z; Bian Z; Yang X; Tao K
    Tumour Biol; 2017 Jul; 39(7):1010428317709127. PubMed ID: 28714366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype.
    Lee K; Jang MH; Chung YR; Lee Y; Kang E; Kim SW; Kim YJ; Kim JH; Kim IA; Park SY
    Hum Pathol; 2017 Mar; 61():111-120. PubMed ID: 27989787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.
    Mesquita B; Lopes P; Rodrigues A; Pereira D; Afonso M; Leal C; Henrique R; Lind GE; Jerónimo C; Lothe RA; Teixeira MR
    Breast Cancer Res Treat; 2013 Feb; 138(1):37-45. PubMed ID: 23329352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
    Lin CH; Liu JM; Lu YS; Lan C; Lee WC; Kuo KT; Wang CC; Chang DY; Huang CS; Cheng AL
    J Clin Pathol; 2013 Feb; 66(2):140-5. PubMed ID: 23268322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of indonesian breast cancers with different molecular subtypes.
    Widodo I; Dwianingsih EK; Triningsih E; Utoro T; Soeripto
    Asian Pac J Cancer Prev; 2014; 15(15):6109-13. PubMed ID: 25124582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Aleskandarany MA; Pigera M; Alsaleem M; Alsaeed S; Kariri Y; Nolan CC; Diez-Rodriguez M; Johnston S; Mongan NP; Fujii T; Shirabe K; Martin SG; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2018 Nov; 172(1):61-68. PubMed ID: 30056565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of primed in situ labelling in determination of HER-2 gene amplification and CEN-17 status in breast cancer tissue.
    Salimi M; Mozdarani H; Majidzadeh-A K
    Asian Pac J Cancer Prev; 2012; 13(1):329-37. PubMed ID: 22502695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular subtypes of breast cancer in South Asian population by immunohistochemical profile and Her2neu gene amplification by FISH technique: association with other clinicopathologic parameters.
    Hashmi AA; Edhi MM; Naqvi H; Khurshid A; Faridi N
    Breast J; 2014; 20(6):578-85. PubMed ID: 25219294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.